MedPath

To investigate the correlation between serum bile acid level less than 40 micro mol/L in pregnancies affected with intrahepatic cholestasis of pregnancy(liver problem associated to pregnancy) and maternal and fetal outcomes

Not Applicable
Conditions
Health Condition 1: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium
Registration Number
CTRI/2018/10/016128
Lead Sponsor
Max Smart Super Speciality Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pregnant women presenting with pruritis with elevated liver enzymes

Primigravida or Multigravida

Spontaneous or IVF conception

Singleton or Twins

Exclusion Criteria

History of cholelithiasis

Chronic liver disease

Hepatitis A,B,C,E

Any other cause of raised liver function tests

Dermatological cause of pruritis

Allergic disorder

Pre eclampsia and HELLP

Patient refusal

Patient with pruritis but no elevation of liver enzymes

Pregnancy ending before 24 weeks gestation

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate maternal and neonatal outcomes in Intrahepatic Cholestasis of pregnancy with Serum Bile Acids less than 40 micro mol per litre <br/ ><br>Timepoint: Until delivery
Secondary Outcome Measures
NameTimeMethod
To determine the frequency of serum bile acid measurement in these patientsTimepoint: 2 weeks;To determine the optimal timing of delivery with close monitoring in these patientsTimepoint: 40 weeks gestation
© Copyright 2025. All Rights Reserved by MedPath